Company intelligence / Profile preview

BioModels

Waltham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

BioModels provides highly translational, predictive rodent disease models for preclinical efficacy and mechanism-of-action studies, supporting more than 100 therapeutics’ progression from bench to clinic; they are not a development-stage company but a CRO service provider.

Therapeutic areas: OncologyImmunologyOtherPulmonology
Modalities: Small moleculeBiologicMonoclonal antibodyCell therapyProteinPeptideAntibodyAntibody-drug conjugateRNA therapyGene therapyRecombinant proteinOncolytic virus therapyVaccineNanoparticleDeviceOther (custom preclinical and translational models)
Industry: Drug Discovery Services

Partnerships

Collaborated with over 300 unique biotechnology and pharmaceutical companiesWorks with academic institutions (names not specified)

Beyond the preview

Go deeper on BioModels.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioModels.

Explore the full profile